Strategic Lab Value hc1 positions its platform as turning laboratories into strategic assets through data management, analytics, and workflow automation powered by AI. Sales opportunities include selling to health systems looking to monetize lab data, improve patient outcomes, and drive revenue growth via analytics-driven lab optimization.

Expansion & Partnerships Recent partnerships and integrations, such as with Simple HealthKit and Accumen, indicate a growth strategy through ecosystem collaborations. Target opportunities involve joint deployments with health systems and reference labs to extend hc1’s analytics across care pathways and reduce IT disruption.

Clinical-AI Solve hc1 emphasizes actionable insights and risk signals in lab data to improve care quality and financial performance. Upsell avenues include AI-driven risk detection modules, lab performance analytics, and decision-support features that align with value-based care and operational excellence.

Manageable Scale With a mid-market footprint (51-200 employees, revenue in the tens of millions) hc1 targets health systems seeking scalable lab analytics without heavy IT burden. Sales plays can highlight rapid deployment, cloud-based solutions, and integration with existing lab and health IT ecosystems.

Industry Credibility A track record of lab-focused deployments, funding history, and notable customers (e.g., Michigan Medicine labs via MLabs) signals credibility. Use this to pursue larger regional health systems and labs looking for proven, scalable analytics partnerships that support compliance and outcomes.